Company
Headquarters: Mannedorf, Switzerland
Employees: 2,050
CEO: Dr. Achim von Leoprechting
CHF4.31 Billion
CHF as of July 1, 2023
US$4.82 Billion
Company | Market Cap (USD) |
---|---|
![]() |
$116.08 B |
![]() |
$84.47 B |
![]() |
$73.65 B |
![]() |
$40.22 B |
![]() |
$39.96 B |
Company | Market Cap (USD) |
---|---|
![]() |
$428.70 B |
![]() |
$417.05 B |
![]() |
$412.24 B |
![]() |
$329.83 B |
![]() |
$275.82 B |
Tecan Group Ltd. provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. It operates through Life Sciences Business and Partnering Business segments. The company develops, produces, markets, and supports automated workflow solutions, including laboratory instruments, software packages, application knowhow, services, consumables, and spare parts; bioanalytical instruments, such as microplate readers and washers; and consulting, and service and consumables for genomics, protein analysis, and cell and tissue analysis. It also develops and manufactures laboratory instrument manufacturers with essential components comprising precision pumps, valves, robotic arms, and developer software for life science research, diagnostics, and various other industries; platform-based automation solutions for various molecular diagnostic tests; and dedicated automation solutions. The company operates in Switzerland and Other European countries, North America, Asia, and internationally. Tecan Group Ltd. was founded in 1980 and is headquartered in Männedorf, Switzerland.
Tecan Group Ltd has the following listings and related stock indices.
Stock: SIX: TECN
Stock: OTC: TCHBF